Skip to main content
. 2021 Apr 20;23(5):384–391. doi: 10.1089/dia.2020.0507

Table 3.

Glycemic Outcomes by Study Phases (Baseline, Supervised Hotel and Home)

Overall
 
Mean ± SD or median (quartiles)
P
Glycemic outcomes Baseline (B) SH Home (H) SH vs. B H vs. B H vs. SH
Percent <50 mg/dL (%) 0.2 (0%–0.9%) 0.2 (0.1%–0.4%) 0 (0%–0.3%) 0.922 0.148 0.055
Percent <54 mg/dL (%) 0.6 (0.1%–1.6%) 0.6 (0.4%–0.8%) 0.1 (0%–0.7%) 0.966 0.074 0.024
Percent <60 mg/dL (%) 1.6 (0.3%–2.8%) 1.4 (1%–1.8%) 0.2 (0%–1.2%) 0.898 0.042 0.024
Percent <70 mg/dL (%) 3.7 (1.5%–6.4%) 5 (3.3%–5.7%) 1.5 (0.4%–2.9%) 0.233 0.052 0.002
Percent 70–140 mg/dL (%) 41.8 ± 15.9 58.8 ± 17 46.8 ± 12.5 0.007 0.319 0.006
Percent 70–180 mg/dL (%) 61.7 ± 16.1 76.5 ± 15.5 68 ± 12.4 0.001 0.125 0.021
Percent >180 mg/dL (%) 34.1 ± 17.3 18.6 ± 14.9 30.1 ± 12.2 0.001 0.343 0.003
percent >250 mg/dL (%) 12.1 ± 9.4 3.6 ± 5.1 8.8 ± 8.7 0.003 0.153 0.004
Percent >300 mg/dL (%) 3.4 (0.6%–5.4%) 0 (0%–0%) 0.9 (0%–2.3%) 0.004 0.027 0.074
Mean CGM (mg/dL) 161.1 ± 28.1 134 ± 20.5 155.2 ± 18.3 0.001 0.42 <0.001
Glucose variability (CV, %) 39.1 ± 5.9 34.6 ± 4.6 35.5 ± 4.2 0.0498 0.047 0.53
Total insulin [U/(kg·day)] 0.67 ± 0.15 0.63 ± 0.18 0.74 ± 0.15 0.232 <0.001 0.009
Total CHO (g/day) 106.5 ± 31.4 123.6 ± 53.8 129.8 ± 40.5 0.297 0.002 0.447
Number of hypoglycemic events 2.13 ± 1.36 2.76 ± 0.85 1.19 ± 1.06 0.134 <0.001 0.100
Percent time in closed loop (%) 98.7 (93.4%–99.5%) 97.4 (95%–98.7%) 0.614
Daytime (7 am–11 pm)
  Baseline (B) SH Home (H) SH vs. B H vs. B H vs. SH
Percent <50 mg/dL (%) 0 (0%–0.9%) 0.3 (0%–0.4%) 0 (0%–0.4%) 0.375 0.820 0.469
Percent <54 mg/dL (%) 0.3 (0.1%–1.4%) 0.7 (0%–1.1%) 0.1 (0%–1%) 0.898 0.098 0.160
Percent <60 mg/dL (%) 0.7 (0.4%–3.6%) 1.7 (0.6%–2.4%) 0.3 (0%–1.8%) 0.831 0.054 0.064
Percent <70 mg/dL (%) 3.6 (1.5%–7.2%) 6.2 (4.3%–8.4%) 1.9 (0.6%–3.5%) 0.092 0.077 0.001
Percent 70–140 mg/dL (%) 42.8 ± 15 58.8 ± 17.1 44.1 ± 11.9 0.006 0.750 0.001
Percent 70–180 mg/dL (%) 63.7 ± 15.1 75.5 ± 14.9 65.1 ± 12.9 0.007 0.667 0.007
Percent >180 mg/dL (%) 31.5 ± 16.5 18.4 ± 14.9 32.6 ± 13 0.004 0.788 0.001
Percent >250 mg/dL (%) 10 ± 9.3 3.8 ± 5.3 9 ± 8.6 0.012 0.663 0.002
Percent >300 mg/dL (%) 2.1 (0%–5.5%) 0 (0%–0.1%) 0.6 (0%–3.3%) 0.008 <0.001 0.078
Mean CGM (mg/dL) 157.1 ± 28.4 132.7 ± 21.7 157.2 ± 18.9 0.002 0.984 <0.001
Glucose variability (CV, %) 38.7 ± 6.3 35.7 ± 4.7 35.7 ± 4.8 0.188 0.100 0.978
Total Insulin [U/(kg·day)] 0.55 ± 0.12 0.51 ± 0.15 0.61 ± 0.13 0.317 <0.001 0.013
Total CHO (g/day) 103.5 ± 29.6 120.8 ± 53.8 126.6 ± 40.5 0.308 0.006 0.546
Number of hypoglycemic events 1.71 ± 1.18 2.42 ± 0.9 1.03 ± 0.93 0.084 0.001 0.122
Night (11 pm–7 am)
  Baseline (B) SH Home (H) SH vs. B H vs. B H vs. SH
Percent <50 mg/dL (%) 0 (0%–0%) 0 (0%–1.2%) 0 (0%–0%) 0.500 0.563 0.125
Percent <54 mg/dL (%) 0 (0%–1%) 0 (0%–1.3%) 0 (0%–0%) 0.594 0.375 0.063
Percent <60 mg/dL (%) 0.7 (0%–2.2%) 0 (0%–2.4% 0 (0%–0% 0.945 0.098 0.063
Percent <70 mg/dL (%) 2.1 (1.4%–4.9% 1.8 (0%–4.8% 0 (0%–1.3% 0.413 0.105 0.371
Percent 70–140 mg/dL (%) 39.8 ± 19.9 58.8 ± 21.9 53.1 ± 24.5 0.028 0.113 0.476
Percent 70–180 mg/dL (%) 57.8 ± 19.7 78.6 ± 21.4 74.5 ± 18.8 0.003 0.019 0.531
Percent >180 mg/dL (%) 38.9 ± 21.1 18.9 ± 19 24.4 ± 18.7 0.003 0.042 0.376
Percent >250 mg/dL (%) 15.9 ± 14 3.2 ± 5.1 8.3 ± 10.7 0.007 0.100 0.044
Percent >300 mg/dL (%) 2.1 (0%–6.2% 0 (0%–0% 0 (0%–0.1% 0.078 <0.001 0.625
Mean CGM (mg/dL) 168.3 ± 33.8 136.3 ± 23.1 150.4 ± 27.2 0.008 0.102 0.087
Glucose variability (CV, %) 37.2 ± 5.8 29.6 ± 8 30.8 ± 7.3 0.031 0.024 0.619
Total Insulin [U/(kg·day)] 0.13 ± 0.04 0.12 ± 0.05 0.12 ± 0.03 0.612 0.782 0.879
Total CHO (g/day) 3 ± 6.8 2.9 ± 6.9 3.2 ± 5.2 0.878 0.311 0.394
Number of hypoglycemic events 0.48 ± 0.36 0.39 ± 0.32 0.19 ± 0.32 0.615 0.200 0.175

P values in bold are statistically significant (P < 0.05)

SH, outpatient supervised hotel.